The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations (Q37950143)

25 August 2017

The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations (English)

1 reference

25 August 2017

1 reference

1 reference

Peter Svenssen Munksgaard

series ordinal

1

1 reference

PubMed ID

22032835

25 August 2017

Jan Blaakaer

series ordinal

2

1 reference

PubMed ID

22032835

25 August 2017

language of work or name

English

0 references

publication date

26 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

124

1 reference

25 August 2017

1

1 reference

25 August 2017

164-169

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

25 August 2017

1 reference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

New considerations for the pathogenesis of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Ovarian endometrioma--risks factors of ovarian cancer development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Endometriosis and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Histologic transformation of benign endometriosis to early epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Prevalence of ovarian endometriosis in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Site of origin of epithelial ovarian cancer: the endometriosis connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Benign or malignant ovarian neoplasms and ovarian endometriomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Prevalence of endometriosis in malignant epithelial ovary tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Stage I ovarian carcinoma: different clinical pathologic patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Ovarian endometriosis associated with ovarian cancer and endometrial-endocervical polyps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Ovarian and extraovarian endometriosis-associated cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Ovarian atypical endometriosis: its close association with malignant epithelial tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Epithelial Abnormalities in Cystic Ovarian Endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Ovarian tumors associated with atypical endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

The clonal evolution of tumor cell populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Monoclonal origin of endometriotic cysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Clonality analysis of bilateral ovarian endometrial cysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Resolution of clonal origins for endometriotic lesions using laser capture microdissection and the human androgen receptor (HUMARA) assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Analysis of the clonality of ectopic glands in peritoneal endometriosis using laser microdissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Does endometriosis really have premalignant potential? A clonal analysis of laser-microdissected tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Molecular genetic evidence that endometriosis is a precursor of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Common genetic changes between endometriosis and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Microsatellite DNA assays reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci in patients with endometriosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

7 January 2021

TP53 and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

The role of p53 mutation in the carcinomas arising from endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Analysis of p53 and ras gene mutations in endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

ARID1A mutations in endometriosis-associated ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Role of iron in carcinogenesis: cancer as a ferrotoxic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

The role of iron in the pathogenesis of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Inflammation and cancer: back to Virchow?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Chronic immune activation and inflammation as the cause of malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Immunobiology of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

The role of cytokines in endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Endometriosis and ovarian cancer: thoughts on shared pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Human growth hormone and interleukin-6 are upregulated in endometriosis and endometrioid adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Distinct regulation of cyclooxygenase-2 by interleukin-1beta in normal and endometriotic stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Hormone therapy and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

PROGINS receptor gene polymorphism is associated with endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

Are all pelvic (nonuterine) serous carcinomas of tubal origin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.001

10.1016/J.YGYNO.2011.10.001

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22032835